US · TVRD
Tvardi Therapeutics, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Sugar Land, TX 77021
Price · as of 2026-07-02
$2.02
Market cap 31.66M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $694.80 | ||||
| 2021 | $435.24 | $606.13 | $75.52 | $0.00 | $4,473.41 |
| 2022 | $218.16 | $193.83 | $48.18 | $0.00 | $0.00 |
| 2023 | $35.32 | $32.38 | $0.00 | $0.00 | $502.85 |
| 2024 | $14.76 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| TVRD | Tvardi Therapeutics, Inc. | $2.02 | 31.66M | +5,729% | +192% | — | +126,768% | -0.32 | -4.89 | 3.15 | -0.46 | -6596.00% |
| CALC | CalciMedica, Inc. | $0.87 | 13.74M | — | — | — | — | -1.84 | 1.75 | — | -0.27 | — |
| ELUT | Elutia Inc. | $1.12 | 49.51M | — | — | +535% | — | — | — | — | — | — |
| FGEN | FibroGen, Inc. | $9.07 | 36.69M | +230% | -59% | — | +42% | -19.49 | -4.11 | 31.31 | -6.67 | -3671.00% |
| LTRN | Lantern Pharma Inc. | $3.50 | 44.66M | — | — | — | — | -1.90 | 1.86 | — | -0.70 | — |
| LVTX | LAVA Therapeutics N.V. | $1.74 | 45.77M | +2,166% | +1,689% | — | — | -1.54 | 1.39 | 3.22 | 1.39 | 7701.00% |
| PDSB | PDS Biotechnology Corpora… | $1.07 | 59.72M | — | — | — | — | -1.19 | 2.36 | — | -0.74 | — |
| RVPH | Reviva Pharmaceuticals Ho… | $0.43 | 1.48M | — | — | — | — | -1.27 | 46.91 | — | -0.84 | — |
| TPST | Tempest Therapeutics, Inc… | $1.73 | 7.68M | — | — | — | — | -7.25 | 15.85 | — | -7.18 | — |
| XLO | Xilio Therapeutics, Inc. | $8.52 | 50.97M | — | — | — | — | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($5.90 ÷ $2.02) − 1 = +192.08% (DCF, example).